How many FDA warning letters has RUBICON RESEARCH received?

Argus HQ has not recorded an FDA warning letter for RUBICON RESEARCH in our current dataset.

What FDA recalls has RUBICON RESEARCH issued?

Argus HQ has not recorded an FDA recall tied to RUBICON RESEARCH in our current dataset.

Is RUBICON RESEARCH FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 1 approval record for RUBICON RESEARCH. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

RUBICON RESEARCH

Name: FDA Enforcement Actions Against RUBICON RESEARCH
Creator: Argus HQ
License: https://argushq.ai/methodology

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_approval · anda2026-06-23
RUBICON RESEARCH — ANDA approval: PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (unspecified)

Frequently asked questions

How many FDA warning letters has RUBICON RESEARCH received?: Argus HQ has not recorded an FDA warning letter for RUBICON RESEARCH in our current dataset.
What FDA recalls has RUBICON RESEARCH issued?: Argus HQ has not recorded an FDA recall tied to RUBICON RESEARCH in our current dataset.
Is RUBICON RESEARCH FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 1 approval record for RUBICON RESEARCH. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.